LCID · Lucid Group, Inc.
10-Q filed 2026-05-05 period 2026-03-31
30 Distress
confidence high · source filing on SEC.gov ↗
- Post-quarter capital raises in April 2026 totaled over $1.5B, including a $550M Series C preferred stock issuance to Ayar, a $200M common stock placement to Uber, a $291.5M public offering, and a $500M DDTL borrowing.
- A workforce reduction plan (the 2026 Plan) was initiated in February 2026, resulting in $37.9M of restructuring charges in Q1 2026 out of an estimated $40M total.
- Deliveries of the Lucid Gravity were disrupted for 29 days during Q1 2026 due to a supplier quality issue with the second-row seats, impacting the company's ability to meet customer demand.
Filing Health Score pillars
Profitability 25%
15
Revenue grew 20% to $282.5M due to the Lucid Gravity ramp-up, but gross margin deteriorated to (110.4)% from (97.2)% due to higher inventory write-downs and tariff impacts, leading to an increased operating loss of $989.5M (MD&A - Results of Operations).
Balance sheet 20%
25
Cash and investments of $714.0M are outweighed by total debt of over $2.75B, with a tight current ratio of 1.02 and ongoing share dilution (Balance Sheets, MD&A - Liquidity and Capital Resources).
Cash generation 20%
10
Operating cash outflow of $1,185.7M exceeded the net loss of $1,028.3M, and with capital expenditures of $253.2M, free cash flow was deeply negative at $(1,438.8)M, representing high capex intensity (Statements of Cash Flows).
Risk flags 20%
45
While there is no going-concern warning, the company faces severe risks including an accumulated deficit of $16.6B, heavy reliance on related-party funding (Ayar/PIF), and recent supplier quality issues that disrupted Lucid Gravity deliveries for 29 days (Note 1 - Description of Business, Risk Factors).
Mgmt signal 15%
65
Management is executing major restructuring with a $37.9M workforce reduction charge and has secured substantial post-quarter financing of over $1.5B alongside a transition to a new CEO, Silvio Napoli (MD&A - Recent Developments).
Key metrics (Three Months Ended March 31, 2026)
net income: $(1,028,344) thousand
cash and equivalents: $700,356 thousand
total debt: $2,755,293 thousand
shares outstanding: 330,144,583 shares
revenue: $282,465 thousand
period: Three Months Ended March 31, 2026
operating cash flow: $(1,185,659) thousand
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.